Article | Published:

Clinical Systems for the Production of Human Cells and Tissues

Bio/Technologyvolume 13pages449453 (1995) | Download Citation



Ex vivo cell production systems are on the verge of changing clinical practice

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Koller, M.R., Emerson, S.G., and Palsson, B.Ø. 1993. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82(2): 378–84.

  2. 2

    The Aastrom Cell Production System (Aastrom CPS) is in its prototype stage, and not yet approved or available for sale. Although initially targeted for use with bone-marrow-derived stem-cell mixtures, the Aastrom CPS has also been demonstrated to efficiently produce cells of different lineages and from different sources.

Download references

Author information

Author notes

  1. R.Douglas Armstrong, Walter C. Ogier and James Maluta: R. Douglas Armstrong is President and CEO, Walter C. Ogier is Director of marketing, and James Maluta is Vice president of product development


  1. Aastrom Biosciences, P.O. Box 376, Ann Arbor, MI, 48106

    • R.Douglas Armstrong
    • , Walter C. Ogier
    •  & James Maluta


  1. Search for R.Douglas Armstrong in:

  2. Search for Walter C. Ogier in:

  3. Search for James Maluta in:

About this article

Publication history

Issue Date